Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan versus placebo and ACE inhibitor continuation in adults with COVID-19, including patients with or without chronic kidney disease
2020-001431-27Phase 2Terminated
- Sponsor
- Klinikum St. Georg
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of valsartan in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Klinikum St. Georg. Primary endpoint: Combined clinical improvement. Started Apr 2020; status: terminated.
02
Drugs
valsartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001431-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001431-27.